walgreens
Ana Cruz
Comprehensive Case Analysis of Walgreens Company
Abstract:
This paper will provide insight into the strengths, weaknesses, opportunities, and threats of the Walgreens Company, the nation’s leading drugstore chain. The company’s key stakeholders – customers, employees and the community are also identified and an explanation provided as to how the company is satisfying the needs and wants of each stakeholder type. This paper analyzes the strengths of the company as the industry leader with its wide portfolio of products and services, as well as establishing the benchmark for growth through acquisitions. The company’s weaknesses include prescription errors resulting in death and being unable to keep pace with a price competitive structure against large discounters. Walgreens is positioned to capitalize on the growing e-prescription demand and benefit from the recent health care reform policies. Has negatively impacted customer count resulting in a top line revenue decrease. Finally, this paper will conclude with my decision as a mutual fund manager to invest in Walgreens.
Case Summary:
Introduction:
Walgreen Co. (Walgreens) and its subsidiaries operate a drugstore chain in the United States. The company provides its customers with multichannel access to consumer goods and services, and pharmacy, health and wellness services in communities across America. The firm currently operates two mail-order facilities and has 7,752 retail drug stores located across all 50 US states, Guam, Puerto Rico, and the District of Columbia. Prescription drugs account for 65% of all sales, with the rest coming from front-end store purchases. Walgreen Co. is ranked number 32 on the Fortune 500 list and is currently trading stock on the NYSE and NASDAQ stock exchanges.
History:
Opening its first store in 1901, Charles R. Walgreen started the iconic drugstore chain on the south side of Chicago. Along with selling prescription and over the counter drugs,
Comprehensive Case Analysis of Walgreens Company
Abstract:
This paper will provide insight into the strengths, weaknesses, opportunities, and threats of the Walgreens Company, the nation’s leading drugstore chain. The company’s key stakeholders – customers, employees and the community are also identified and an explanation provided as to how the company is satisfying the needs and wants of each stakeholder type. This paper analyzes the strengths of the company as the industry leader with its wide portfolio of products and services, as well as establishing the benchmark for growth through acquisitions. The company’s weaknesses include prescription errors resulting in death and being unable to keep pace with a price competitive structure against large discounters. Walgreens is positioned to capitalize on the growing e-prescription demand and benefit from the recent health care reform policies. Has negatively impacted customer count resulting in a top line revenue decrease. Finally, this paper will conclude with my decision as a mutual fund manager to invest in Walgreens.
Case Summary:
Introduction:
Walgreen Co. (Walgreens) and its subsidiaries operate a drugstore chain in the United States. The company provides its customers with multichannel access to consumer goods and services, and pharmacy, health and wellness services in communities across America. The firm currently operates two mail-order facilities and has 7,752 retail drug stores located across all 50 US states, Guam, Puerto Rico, and the District of Columbia. Prescription drugs account for 65% of all sales, with the rest coming from front-end store purchases. Walgreen Co. is ranked number 32 on the Fortune 500 list and is currently trading stock on the NYSE and NASDAQ stock exchanges.
History:
Opening its first store in 1901, Charles R. Walgreen started the iconic drugstore chain on the south side of Chicago. Along with selling prescription and over the counter drugs,